Opus Genetics, Inc.

Nasdaq:IRD

Pharmaceutical Preparations·DURHAM, NC

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/12/26	→
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

Earnings Releases (8-K)

24 shown

Filed	Period
3/10/26	Q1 FY2026	→
2/19/26	Q1 FY2026	→
11/12/25	Q4 FY2025	→
8/13/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
↓

News (8-K)

56 shown

Filed	Type	Description
1/12/26	Reg FD	Regulation FD Disclosure	→
1/8/26	Reg FD	Regulation FD Disclosure	→
12/19/25	Other	Other Events	→
11/6/25	Agreement	Entry into a Material Definitive Agreement	→
11/6/25	Reg FD	Regulation FD Disclosure	→
9/30/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/22/26	S-8	S-8	→
11/6/25	FWP	FWP	→
11/6/25	424B5	424B5	→
9/26/25	S-8	S-8	→
9/10/25	S-8	S-8	→
6/26/25	424B5	424B5	→
↓

Filing History(979 filings)

TypeDateAccessionPeriodSize

PRE 14A

Mar 12, 2026

0001140361-26-009254PRE 14A

Apr 20, 2026

7.2 MB

10-K

Mar 12, 2026

0001140361-26-00924710-K

Dec 31, 2025

11.4 MB

8-K

Mar 10, 2026

0001140361-26-0086218-K

Mar 10, 2026

295.2 KB

8-K

Feb 19, 2026

0001140361-26-0061768-K

Feb 13, 2026

810.0 KB

Feb 17, 2026

0000905148-26-000904FORM 4

Feb 12, 2026

4.9 KB

SCHEDULE 13G/A

Feb 17, 2026

0001193125-26-054534

—

11.7 KB

SCHEDULE 13G

Feb 17, 2026

0001193125-26-052859

—

124.0 KB

SCHEDULE 13G/A

Feb 13, 2026

0001104659-26-015341

—

11.4 KB

Jan 26, 2026

0000905148-26-000359

Jan 22, 2026

4.8 KB

Jan 26, 2026

0000905148-26-000358

Jan 22, 2026

4.8 KB

Jan 26, 2026

0000905148-26-000357

Jan 22, 2026

4.7 KB

Jan 26, 2026

0000905148-26-000356

Jan 22, 2026

4.8 KB

Jan 26, 2026

0000905148-26-000355

Jan 22, 2026

4.8 KB

Jan 26, 2026

0000905148-26-000354

Jan 22, 2026

4.7 KB

S-8

Jan 22, 2026

0001140361-26-002066S-8

—

205.0 KB

Jan 21, 2026

0000905148-26-000282

Jan 18, 2026

4.7 KB

Jan 13, 2026

0000905148-26-000164

Jan 10, 2026

4.7 KB

8-K

Jan 12, 2026

0001140361-26-0009138-K

Jan 12, 2026

6.2 MB

Jan 8, 2026

0000905148-26-000088

Jan 6, 2026

5.9 KB

8-K

Jan 8, 2026

0001140361-26-0006158-K

Jan 8, 2026

184.3 KB

Jan 5, 2026

0000905148-26-000036

Jan 1, 2026

4.9 KB

Jan 5, 2026

0000905148-26-000031

Jan 1, 2026

4.9 KB

Jan 5, 2026

0000905148-26-000028

Jan 1, 2026

4.9 KB

Jan 5, 2026

0000905148-26-000027

Jan 1, 2026

4.9 KB

Dec 31, 2025

0000905148-25-004511

Dec 29, 2025

9.4 KB

25 filings shown

Filed	Form	Description
3/12/26	PRE 14A	PRE 14A	→
4/14/25	DEFA14A	ADDITIONAL DEFINITIVE PROXY SOLICITATING MATERIALS	→
4/11/25	DEFA14A	ADDITIONAL DEFINITIVE PROXY SOLICITATING MATERIALS	→
4/10/25	DEFA14A	ADDITIONAL DEFINITIVE PROXY SOLICITATING MATERIALS	→
4/7/25	DEFA14A	ADDITIONAL DEFINITIVE PROXY MATERIAL	→
4/2/25	DEFC14A	PRELIMINARY PROXY STATEMENT	→
↓

Opus Genetics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(979 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/17/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
↓